Sold ONLY to licensed veterinarians and pharmacies. Submit license if not already on file. Fax :: 800-640-3274

Licensed Professional Price: $0.82

Rx: Copy of License Required [No Prescriptions Please]

Stock Status:In StockProduct Code:10640

Qty:

Description

CLAVAMOX TABLETS

(amoxicillin trihydrate/clavulanate potassium)

Clavamox Tablets - Pfizer is an antibiotic suspension for dogs and cats effective against a broad range of bacterial infections.

Dogs: Skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: Staphylococcus, Streptococcus and E. coli.

Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Clavamox has been shown to be clinically effective for treating cases of canine periodontal disease.

Cats: Skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: Staphylococcus aureus,Streptococcus,E. coli, Pasteurella.

Dogs: The recommended dosage is 6.25 mg/lb of body weight twice a day. Skin and soft tissue infections such as abscesses, cellulitis, wounds, superficial/juvenile pyoderma, and periodontal infections should be treated for 5-7 days or for 48 hours after all symptoms have subsided. If no response is seen after 5 days of treatment, therapy should be discontinued and the case reevaluated. Deep pyoderma may require treatment for 21 days; the maximum duration of treatment should not exceed 30 days.

Cats: The recommended dosage is 62.5 mg twice a day. Skin and soft tissue infections such as abscesses and cellulitis/dermatitis should be treated for 5-7 days or 48 hours after all symptoms have subsided, not to exceed 30 days. If no response is seen after 3 days of treatment, therapy should be discontinued and the case reevaluated.

Urinary tract infections may require treatment for 10-14 days or longer. The maximum duration of treatment should not exceed 30 days.

Warning: Safety of use in pregnant or breeding animals has not been determined. For use in dogs and cats only.

Actions:
Clavamox is stable in the presence of gastric acid and is not significantly
influenced by gastric or intestinal contents. The 2 components are rapidly
absorbed resulting in amoxicillin and clavulanic acid concentrations in
serum, urine, and tissues similar to those produced when each is
administered alone.

Amoxicillin and clavulanic
acid diffuse readily into most body tissues and fluids with the exception of
brain and spinal fluid, which amoxicillin penetrates adequately when
meninges are inflamed. Most of the amoxicillin is excreted unchanged in the
urine. Clavulanic acid's penetration into spinal fluid is unknown at this
time. Approximately 15% of the administered dose of clavulanic acid is
excreted in the urine within the first 6 hours.

Clavamox combines the
distinctive properties of a broad-spectrum antibiotic and a ?-lactamase
inhibitor to effectively extend the antibacterial spectrum of amoxicillin to
include ?-lactamase as well as non-?-lactamase-producing aerobic and
anaerobic organisms.

Microbiology:
Amoxicillin is bactericidal in action and acts through the inhibition of
biosynthesis of cell wall mucopeptide of susceptible organisms. The action
of clavulanic acid extends the antimicrobial spectrum of amoxicillin to
include organisms resistant to amoxicillin and other ?-lactam antibiotics.
Amoxicillin/clavulanate has been shown to have a wide range of activity
which includes ?-lactamase-producing strains of both gram-positive and
gram-negative aerobes, facultative anaerobes, and obligate anaerobes.

Studies have demonstrated that
both aerobic and anaerobic flora are isolated from gingival cultures of dogs
with clinical evidence of periodontal disease. Both gram-positive and
gram-negative aerobic and anaerobic subgingival isolates indicate
sensitivity to amoxicillin/clavulanic acid during antimicrobial
susceptibility testing.

Federal law restricts this drug to use by or on the order of a licensed veterinarian

“I founded Medi-Vet back in 1998, because I believe no animal should go without proper healthcare due to inflated costs. This belief still guides us to this day.” – Dr. Kent P. Walker, DVM, Founder and CEO